Experiences with Pulmonary embolism (PE)

This page shows detailed information about a disease such as statistics, patient reviews and related articles.

Also known as:
---
ICD10/11 Code: I26
ICD10/11 Group: I00-I99, Diseases of the circulatory system
reviews
Pulmonary embolism (PE)
Also known as: ---
ICD10/11 Code: I26, ICD10/11 Group: I00-I99, Diseases of the circulatory system

Read our patient's reviews about Pulmonary embolism (PE)

Filter reviews by...

hide filters...
translation feature available for reviews from other countries

No recent reviews to display.

We are sorry but at the moment we do not have any recent reviews to show you. Contribute to this platform and share your experience with other patients. Choose one of the options below.


Most used medicines for this disease


Reviews from the most used medicines for this disease

Xarelto

29/07/2017 | | 43moderated by Charlotte
Rivaroxaban (20mg) for pulmonary embolism (PE)

Been taking xarelto 20 mg for about 6 months. No problems with side effects in the first month, until all of my joints in my body became inflamed. Had some blood tests and it seemed that my blood values (ast and alt) in my liver weren't right. Had an echo and liver biopsy and it transpired that xarelto had affected my liver. Quickly switched to another medicine, but need to have extrad blood te...
> read full review...

Eliquis

27/06/2017 | | 66moderated by Henry
apixaban (5mg) for pulmonary embolism (PE)

I couldn't sleep in the hospital and I told them so every day when the doctors did their rounds and they didn't answer just went away!!!!! itching-pain in my lower legs-can't sleep any more-dead tired-THIS IS THE WORST MEDICINE I HAVE EVEN BEEN PRESCRIBED !!!!!!!
> read full review...

Xarelto

23/06/2017 | | 62moderated by Charlotte
Rivaroxaban (20mg) for pulmonary embolism (PE)

GP and respiratory consultant: you should switch to: Xarelto; no more injections! no more control!: Effective: both doctors said that it works really well...well; then I guess I'll trust them! Start date programmed into my telephone + reminder: PERFECT! No nagging! But there are also risks: I am assuming that they do their job. The question that bothers me is what will it do to me in the long t...
> read full review...

Xarelto

23/05/2017 | | 55moderated by Henry
Rivaroxaban (20mg) for pulmonary embolism (PE)

Because of a massive pulmonary embolism in 2015, I ended up on acenocumarol for 6 months, after which I stopped on the advice of a specialist. In September 2016 I was diagnosed with another massive pulmonary embolism and put on Xarelto. what a relief that you don't have to do a blood test every time you visit the thrombosis clinic to check the INR values. Few if any side effects, just the cold ...
> read full review...

Xarelto

21/01/2017 | | 43moderated by Henry
Rivaroxaban (15mg) for pulmonary embolism (PE)

Had Xarelto, one tablet (15mg) a day, for over three months now. Just some side effects during the first week, mainly headaches. No side effects since.
> read full review...

Xarelto

05/04/2016 | | 61moderated by Susan
Rivaroxaban (20mg) for pulmonary embolism (PE)

Massive bilateral pulmonary embolism and deep vein thrombosis in both legs. I'm really not tolerating this medicine very well but I'm absolutely not allowed to stop or switch to another medicine.
> read full review...

Most reviewed diseases


The content on this page is user-generated content, read and revised before approval to comply with our standards for a condition review or reaction. We do not enforce any proven medical knowledge from our users to allow them to present their experiences. This way, the opinions and experiences described state only the views of the writers and not those of the owner of this website. Remember that these experiences differ from person to person and that you should always contact your doctor or pharmacist for advice on medication.

Copyright © 2008-2024 Insight Pharma Services BV.
All rights reserved.
Most icons from FontAwesome. Some icons made by Prosymbols from www.flaticon.com and licensed as CC 3.0 BY.